SSA
MDT icon

Schonfeld Strategic Advisors’s Medtronic MDT Stock Holding History

Schonfeld Strategic Advisors’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-100,000
Closed -$7.99M – 2381
2024
Q4 		$7.99M Buy
+100,000
New +$8.66M 0.05% 361
2020
Q4 		– Sell
-100,000
Closed -$10.4M – 1749
2020
Q3 		$10.4M Buy
+100,000
New +$10M 0.2% 138

Other funds holding MDT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Schonfeld Strategic Advisors's MDT Position: Q1 2026 in Review

Schonfeld Strategic Advisors sold out of Medtronic (MDT) in Q1 2026, closing a stake of 21,469 shares — an estimated $2.06M sold.

Schonfeld Strategic Advisors first reported a position in MDT in Q1 2016 and held it in 30 quarters. The position peaked at $34.7M in Q4 2022. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Schonfeld Strategic Advisors reported no remaining Medtronic position as of Q1 2026 after selling out during the quarter.
  • Schonfeld Strategic Advisors sold 21,469 Medtronic shares in Q1 2026, an estimated $2.06M.
  • Schonfeld Strategic Advisors first reported a position in Medtronic in Q1 2016 and held it in 30 quarters.
  • Schonfeld Strategic Advisors's Medtronic position peaked at $34.7M in Q4 2022.
  • 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q1 2026, filed 15 May 2026.